Journal article
Immunological considerations for COVID-19 vaccine strategies
Abstract
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most formidable challenge to humanity in a century. It is widely believed that prepandemic normalcy will never return until a safe and effective vaccine strategy becomes available and a global vaccination programme is implemented successfully. Here, we discuss the immunological principles that need to be taken into …
Authors
Jeyanathan M; Afkhami S; Smaill F; Miller MS; Lichty BD; Xing Z
Journal
Nature Reviews Immunology, Vol. 20, No. 10, pp. 615–632
Publisher
Springer Nature
Publication Date
October 2020
DOI
10.1038/s41577-020-00434-6
ISSN
1474-1733
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
Antibodies, ViralBetacoronavirusCOVID-19COVID-19 VaccinesClinical Trials as TopicCoronavirus InfectionsGenetic VectorsHumansImmunity, HerdImmunity, InnateImmunization ScheduleImmunogenicity, VaccinePandemicsPatient SafetyPneumonia, ViralSARS-CoV-2Severe Acute Respiratory SyndromeVaccines, AttenuatedVaccines, DNAVaccines, SubunitVaccines, Virus-Like ParticleViral Vaccines